- Health system cleared in data breach lawsuit (healthcareitnews.com)
An appellate court has cleared Advocate Medical Group of wrongdoing in a class action lawsuit alleging the organization failed to protect patient data following a massive HIPAA data breach… The fact that two plaintiffs to date (out of those four million) have received notification of fraudulent activity, i.e., have suffered actual injury arising…does not show that plaintiffs here face imminent,..impending, or a substantial risk of harm..
- India, EU working to end trade huff over generic drugs (newsdaily.com)
India and the European Union are taking steps to end a trade row sparked by an EU ban on Indian pharmaceutical products that New Delhi responded to by cancelling talks on a free trade accord with its largest trading partner,.. both sides are working to end the row,…European Union said…the India-made pharmaceuticals that drug makers can avoid the ban by submitting fresh test results...
- NCPA Supports Arkansas Law, Decries Shameful PBM Corporation Lawsuit (ncpanet.org)
National Community Pharmacists Association,.. issued the following statement..to champion a generic drug pricing transparency law enacted in Arkansas and to condemn a lawsuit filed on behalf of pharmacy benefit manager corporations to attempt to overturn the common-sense law…bipartisan law to bring more transparency to the generic drug pricing and reimbursement process...
- Will Biosimilars Impact the Cost of Specialty Drugs? (specialtypharmacytimes.com)
Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses whether the R&D cost for biosimilars will affect the overall cost reduction.
- Will delaying Stage 3 meaningful use help with MIPS? (healthcareitnews.com)
Even as stakeholders await the imminent release of the final updates to Stage 3 meaningful use, there's still widespread interest in delaying it... Fueling that fire is… Medicare Merit-Based Incentive Payment System, will attempt to bring all existing quality measures under one umbrella – but no one knows exactly how… details on this is driving physicians and vendors alike into a state of deep concern…
- Diabetes could ‘bankrupt the NHS’ after 60% rise in number of cases, charity warns (independent.co.uk)
An extra 1.2 million people have diabetes now than a decade ago, according to new figures – leading to a warning that its cost could "bankrupt the NHS" (National Health Service) ..The number of those living with the condition has soared by 59.8 per cent since 2005, meaning more than 3.3 million now have it… Prescriptions for diabetes now take up 10 per cent of GP (General Practioner) practices’ annual prescribing budget in England. A total of 47.2 million items were prescribed in the last financial year, at a cost of £860m.($1.34b)...
- Renown Health: Preparing For Growth In Northern Nevada: Medical Facility Expansion In Tahoe Reno Industrial Center (renown.org)
Patients seeking medical care in and around the Tahoe Reno Industrial Center now have convenient access for many medical services…facility …provides the following services: occupational health, physicals for the Department of Transportation and urgent care…the addition of the Tesla gigafactory to the industrial park, the need for new services is only expected to grow…
- The 5 Most Expensive Drugs in the World in 2015 (fool.com)
For the first time in history global pharmaceutical spending crossed the $1 trillion plateau in 2014. Think about that for a moment: $1 trillion equates to 1.3% of global GDP,… looking forward, global pharmaceutical spending is only expected to increase…spending could rise by 30% between 2014 and 2018 to $1.3 trillion… Why.. need to cover research and development and marketing costs…other reasons for rising prescription costs often fly under the radar… world's five most expensive drugs:
- Glybera: $1.21 million
- Soliris: $700,000
- Naglazyme: $485,747
- Vimizim: $380,000
- Elaprase: $375,000
- Logistic Toxicity, An Unmeasured Burden Of Healthcare (forbes.com)
Logistic toxicity might be defined as the administrative burden of healthcare. Chores – like processing medical bills, holding on the phone for providers, filling out and submitting paperwork to insurers – can chew at a healthy person’s time, causing annoyance. For someone who’s chronically ill, these tasks and additional, long-term responsibilities – coordinating frequent medical appointments, and arranging for time off at work, and for childcare or caregiving of another adult – compound the physical and financial toll of disease.
- Nevada Society of Health-System Pharmacists – Annual Meeting: Continuing Education – October 3rd , Reno (nvshp.org)
- Provider Status Update - Christopher Tolopeski, Director of Federal Regulatory Affairs of American Society of Health-System Pharmacists
- Management of Medications in a Hospice and Palliative Care Patient - Justin Kullgren, PharmD, Associate Professor of Pharmacy Practice, South University College of Pharmacy and Hospice and Palliative Care
- Melanoma: Considerations in Pharmacotherapy - Jacob Frick, PharmD, Banner MD Anderson Cancer Center
- Management of Bipolar Disorder - Heather Mooney-Magallon, PharmD, Mental Health and Ambulatory Care, Sierra Nevada VA HCS